SDI Inventory
The Inventory of SDI (SDI.AX) as of Jul 21, 2026 is 27.79 M AUD. In the previous year, Inventory was 28.75 M AUD — a change of -3.34% (lower).
Get this data via API
Financial Data API
Inventory
27.79 MAUD
YoY
-3.34%
Last updated:
Inventory of SDI is 2026 27.79 M AUD. Inventory of SDI was 2025 28.75 M AUD. It decreases by -3.34% lower compared to the previous year.
Access this data via the Eulerpool API
SDI Stock analysis
What does SDI do? SDI Ltd is a British company specializing in the development and manufacture of scientific and medical devices. The company was founded by John Poulter in 1952 and is headquartered in Basingstoke, Hampshire.
The history of SDI Ltd began with the development of scientific measuring devices, particularly instruments for measuring optical signals. Over the years, the company has specialized in the development of devices for medical diagnostics and therapy.
SDI Ltd now operates in various areas. One of its main business fields is microbiology and infection prevention. The company offers a wide range of products including test systems for infectious diseases such as HIV, Hepatitis B and C, tuberculosis, and malaria.
Another business field of SDI Ltd is the development of devices for the diagnosis of cancer and other diseases. The company offers both instruments for tissue sampling as well as automated diagnostic systems.
SDI Ltd is also active in medical technology and offers a wide range of products, from simple instruments like thermal thermometers to complex surgical instruments and implants.
In addition to medical diagnostics and therapy, SDI Ltd is also active in the field of analytical technology. The company offers instruments for chemical analysis, environmental monitoring, and food sampling.
The business model of SDI Ltd is based on the development and manufacture of high-quality and reliable devices for scientific, medical, and industrial use. The company relies on close collaboration with customers and partners to provide innovative solutions for the challenges of modern science and medicine.
An important part of SDI Ltd's business model is research and development. The company invests a significant portion of its revenue in the development of new products and technologies to always offer its customers the latest and best solutions.
Overall, SDI Ltd has established itself as a leading company in the field of scientific and medical devices. The company has a long history of successful product developments and is known for its high quality, reliability, and innovation. With its wide range of products and its commitment to research and development, SDI Ltd is well-equipped to continue playing an important role in science and medicine in the future. SDI is one of the most popular companies on Eulerpool.
Frequently Asked Questions about SDI stock
Inventory of SDI is 27.79 M AUD in 2026.
Access this data via the Eulerpool API
Balance Sheet — SDI
Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets
All Key Metrics — SDI
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth